Efficacy and Safety of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion Administered as Monotherapy in Patients with Parkinson's Disease

被引：0
|
作者：
Aldred, J.
Henriksen, T.
Bouchard, M.
Martinez-Castrillo, J.
Soileau, M.
Spiegel, A.
Bergmann, L.
Gupta, R.
Kukreja, P.
Standaert, D.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
19
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF FOSLEVODOPA/FOSCARBIDOPA CONTINUOUS SUBCUTANEOUS INFUSION ADMINISTERED AS MONOTHERAPY IN PATIENTS WITH PARKINSON'S DISEASE
    Aldred, J.
    Henriksen, T.
    Bouchard, M.
    Martinez-Castrillo, J. C.
    Soileau, M. J.
    Spiegel, A.
    Bergmann, L.
    Gupta, R.
    Kukreja, P.
    Standaert, D. G.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [2] Vyalev - Foscarbidopa/Foslevodopa Subcutaneous Infusion for Parkinson's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2025, 67 (1719):
  • [3] Effects of continuous subcutaneous infusion of foslevodopa/foscarbidopa on quality-of-life in Parkinson's patients
    Gandor, F.
    Bouchard, M.
    Bergmans, B.
    Pahwa, R.
    Isaacson, S.
    Spiegel, A.
    Bergmann, L.
    Jia, J.
    Shah, M.
    Antonini, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 304 - 304
  • [4] Effects of continuous subcutaneous infusion of foslevodopa/foscarbidopa on quality-of-life in Parkinson's patients
    Gandor, F.
    Bouchard, M.
    Bergmans, B.
    Pahwa, R.
    Isaacson, S.
    Spiegel, A.
    Bergmann, L.
    Jia, J.
    Shah, M.
    Waern, J.
    Antonini, A.
    AUSTRALASIAN JOURNAL ON AGEING, 2024, 43 : 32 - 32
  • [5] EFFECTS OF CONTINUOUS SUBCUTANEOUS INFUSION OF FOSLEVODOPA/FOSCARBIDOPA ON SLEEP DYSFUNCTION IN PEOPLE WITH PARKINSON'S
    Hauser, R.
    Bergmans, B.
    Malaty, I.
    Cobb, D.
    Homola, J.
    Bergmann, L.
    Gupta, R.
    Jia, J.
    Shah, M.
    Chaudhuri, K. R.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [6] Patients’ experience with and perspectives on long-term use of continuous subcutaneous infusion of foslevodopa/foscarbidopa in Parkinson’s disease
    Michael Soileau
    Rajeev Kumar
    Ashwini Parab
    Triza Brion
    Kailee White
    Connie H. Yan
    Megha B. Shah
    Pavnit Kukreja
    Maurizio F. Facheris
    Anand Shewale
    Jason Aldred
    Journal of Neurology, 2025, 272 (6)
  • [7] Efficacy and safety of foslevodopa/foscarbidopa subcutaneous infusion in patients with prior deep brain stimulation
    Henriksen, T.
    Martinez-Castrillo, J.
    Huisman, M.
    Dhanani, S.
    Peckham, E.
    Aldred, J.
    Bergmann, L.
    Shah, M.
    Gupta, R.
    Kukreja, P.
    Fung, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 169 - 170
  • [8] EFFICACY AND SAFETY OF FOSLEVODOPA/FOSCARBIDOPA SUBCUTANEOUS INFUSION IN PATIENTS WITH PRIOR DEEP BRAIN STIMULATION
    Henriksen, T.
    Martinez-Castrillo, J. C.
    Huisman, M.
    Dhanani, S.
    Peckham, E.
    Aldred, J.
    Bergmann, L.
    Shah, M.
    Gupta, R.
    Kukreja, P.
    Fung, V. S.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [9] Pharmacokinetics, Safety and Tolerability of Foslevodopa/Foscarbidopa Following Continuous Subcutaneous Infusion to Arm, Thigh and Flank Compared to Abdomen in Parkinson's Disease Patients
    Han, Y.
    Kalluri, H.
    Jeong, A.
    Locke, C.
    Facheris, M.
    Gupta, S.
    Rosebraugh, M.
    MOVEMENT DISORDERS, 2023, 38 : S27 - S27
  • [10] Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease
    Rosebraugh, Matthew
    Voight, Eric A.
    Moussa, Ehab M.
    Jameel, Feroz
    Lou, Xiaochun
    Zhang, Geoff G. Z.
    Mayer, Peter T.
    Stolarik, Deanne
    Carr, Robert A.
    Enright, Brian P.
    Liu, Wei
    Facheris, Maurizio F.
    Kym, Philip R.
    ANNALS OF NEUROLOGY, 2021, 90 (01) : 52 - 61
12345